Houston-based CRO MedSource is growing its service-offering to include the early stages of clinical development and pipeline planning through Investigational New Drug (IND) submissions. The service, rarely offered by CROs, will be provided by a new department-Scientific Development-which will be responsible for delivering a suite of clinical development services to biotech and pharmaceutical companies wishing [...]The post MedSource expands footprint, adds new service line appeared first on CenterWatch News Online.